Sleep and memory complaints in long COVID: an insight into clustered psychological phenotypes

This study evaluated clinical features of individuals with long COVID (5-8 months after diagnosis) who reported sleep and memory problems (62 cases) compared to those without (52 controls). Both groups had a similar mean age (41 39 years). Around 86% of the participants were non-hospitalized at the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PeerJ (San Francisco, CA) CA), 2024-01, Vol.12, p.e16669-e16669, Article e16669
Hauptverfasser: Titze-de-Almeida, Ricardo, Araújo Lacerda, Pedro Henrique, de Oliveira, Edson Pereira, de Oliveira, Mariah Eduarda Ferreira, Vianna, Yngrid Sallaberry Silva, Costa, Amanda Machado, Pereira Dos Santos, Eloísa, Guérard, Louise Marie Coelho, Ferreira, Matheus Augusto de Miranda, Rodrigues Dos Santos, Isabel Cristina, Gonçalves, Jéssica Daniele da Silva, Ginani Ferreira, Gabriel, Souza Titze-de-Almeida, Simoneide, Brandão, Pedro Renato de Paula, Eri Shimizu, Helena, Silva, Andrezza Paula Brito, Delgado-Rodrigues, Raimundo Nonato
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study evaluated clinical features of individuals with long COVID (5-8 months after diagnosis) who reported sleep and memory problems (62 cases) compared to those without (52 controls). Both groups had a similar mean age (41 39 years). Around 86% of the participants were non-hospitalized at the time of infection, and none of them were vaccinated at that point. Subsequently, both cases and controls received the vaccine; however, the vaccination rates differed significantly between the groups (30.7% 51.0%). Cases and controls had similar rates of symptoms at acute COVID phase. However, cases were more likely to experience coryza, dyspnea, headache, and nausea/vomiting during long COVID. Regarding new-onset symptoms in long COVID, 12.9% of cases had dyspnea, and 14.5% experienced nausea/vomiting, whereas in the control group there were only 1.9% and 0.0%, respectively. Cases also had a significantly higher prevalence of persistent headache (22.6% 7.7%), and dyspnea (12.9% 0.0). In addition, cases also showed an increased rate of mental health complaints: disability in daily activities (45.2% 9.6%;  
ISSN:2167-8359
2167-8359
DOI:10.7717/peerj.16669